Exploring in-hospital death from myocardial infarction in Eastern Europe: From the international registry of acute coronary syndromes in transitional countries (ISACS-TC); on the behalf of the working group on coronary pathophysiology & microcirculation of the European Society of Cardiology

Current Vascular Pharmacology

Volumn 12, Issue 6, 2014, Pages 903-909

  Bugiardini, Raffaele ^a   Manfrini, Olivia ^a   Stakić, Marta Majstorović ^a   Cenko, Edina ^a   Boytsov, Sergei ^b   Merkely, Béla ^c   Becker, David ^c   Dilić, Mirza ^d   Vasiljević, Zorana ^e   Koller, Akos ^f,g   Badimon, Lina ^h  

^a UNIVERSITY OF BOLOGNA   (Italy)

^b NATIONAL MEDICAL RESEARCH CENTER FOR THERAPY AND PREVENTIVE MEDICINE   (Russian Federation)

^c SEMMELWEIS UNIVERSITY   (Hungary)

^d University Institute of Cardiovascular Diseases   (Bosnia and Herzegovina)

^e Clinical Center of Serbia   (Serbia)

^f NEW YORK MEDICAL COLLEGE   (United States)

^g UNIVERSITY OF PÉCS   (Hungary)

^h CSIC   (Spain)

Author keywords

Acute myocardial infarction; Bosnia and Herzegovina; Hungary; Mortality rate; Reperfusion therapy; Russian Federation; Serbia; STEMI

Indexed keywords

ACETYLSALICYLIC ACID; ANTITHROMBOCYTIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CLOPIDOGREL; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; ENOXAPARIN; HEPARIN; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR;

ADULT; ARTICLE; BOSNIA AND HERZEGOVINA; DEATH; EASTERN EUROPE; FEMALE; HEALTH CARE QUALITY; HEART INFARCTION; HOSPITAL ADMISSION; HUMAN; HUNGARY; IN HOSPITAL DEATH; MAJOR CLINICAL STUDY; MALE; MORTALITY; OUTCOME ASSESSMENT; PERCUTANEOUS CORONARY INTERVENTION; REPERFUSION; RISK FACTOR; RUSSIAN (PEOPLE); SERBIA; ST SEGMENT ELEVATION MYOCARDIAL INFARCTION; ACUTE CORONARY SYNDROME; AGED; CARDIOLOGY; EPIDEMIOLOGY; INTERNATIONAL COOPERATION; MEDICAL SOCIETY; MICROCIRCULATION; MIDDLE AGED; MYOCARDIAL INFARCTION; REGISTER; TRENDS;

ACUTE CORONARY SYNDROME; AGED; CARDIOLOGY; EUROPE, EASTERN; FEMALE; HOSPITAL MORTALITY; HUMANS; INTERNATIONALITY; MALE; MICROCIRCULATION; MIDDLE AGED; MYOCARDIAL INFARCTION; REGISTRIES; SOCIETIES, MEDICAL;

EID: 84926310160     PISSN: 15701611     EISSN: 18756212     Source Type: Journal    
DOI: 10.2174/157016111206141210122150     Document Type: Article

References (26)

1. Greenberg H, Raymond SU, Leeder SR. Cardiovascular disease and global health: threat and opportunity. Health Aff (Millwood) 2005; Suppl Web Exclusives: W5-31-W5-41.
2. Allender S, Scarborough P, Peto V, et al. European cardiovascular disease statistics, 2008 edition. British Heart Foundation; 2008. Available from URL: http://www.bhf.org.uk/publications/viewpublication.aspx?ps=1001443 (Accessed on January 4, 2013).
3. OECD (2011), Health at a Glance 2011: OECD Indicators, OECD Publishing. http://dx.doi.org/10.1787/health_glance-2011-en (Accessed on January 4, 2013).
4. Hanssen M, Cottin Y, Khalife K, et al. French Registry on Acute ST-elevation and non ST-elevation Myocardial Infarction 2010. FAST-MI 2010. Heart 2012; 98: 699-705.
5. Radovanovic D, Erne P. AMIS Plus: Swiss registry of acute coronary syndrome. Heart 2010; 96: 917-21.
6. Radovanovic D, Urban P, Simon R, et al. Outcome of patients with acute coronary syndrome in hospitals of different sizes. A report from the AMIS Plus Registry. Swiss Med Wkly 2010; 140: 314-22.
7. Poloński L, Gąsior M, Gierlotka M, et al. What has changed in the treatment of ST-segment elevation myocardial infarction in Poland in 2003–2009? Data from the Polish Registry of Acute Coronary Syndromes (PL-ACS). Kardiol Pol 2011; 69: 1109-18.
8. Thygesen K, Alpert JS, Jaffe AS, et al. Third universal definition of myocardial infarction. Eur Heart J 2012; 33: 2551-67.
9. Bugiardini R, Estrada JL, Nikus K, Hall AS, Manfrini O. Gender bias in acute coronary syndromes. Curr Vasc Pharmacol 2010; 8: 276-84.
10. Decarli A, La Vecchia C. Age, period and cohort models: a review of knowledge and implementation in GUM. Riv Stat Appl 1987; 20: 397-410.
11. Khare RK, Courtney DM, Kang R, Adams JG, Feinglass J. The relationship between the emergent primary percutaneous coronary intervention quality measure and inpatient myocardial infarction mortality. Acad Emerg Med 2010; 17: 793-80.
12. Holloway RG, Quill TE. Mortality as a measure of quality: implications for palliative and end-of-life care. JAMA 2007; 298: 802-80.
13. Cohen M, Gensini GF, Maritz F, et al. Prospective evaluation of clinical outcomes after acute ST-segment elevation myocardial infarction in patients who are ineligible for reperfusion therapy: preliminary results from the TETAMI registry and randomized trial. Circulation 2003; 3: 14-2.
14. Zeymer U, Gitt AK, Jünger C, et al. Clopidogrel in addition to aspirin reduces in-hospital major cardiac and cerebrovascular events in unselected patients with acute ST segment elevation myocardial infarction. Thromb Haemost 2008; 99: 155-60.
15. Eagle KA, Nallamothu BK, Mehta RH, et al. Trends in acute reperfusion therapy for ST-segment elevation myocardial infarction from 1999 to 2006: we are getting better but we have got a long way to go. Eur Heart J 2008; 29: 609-61.
16. Fefer P, Hod H, Hammerman H, Boyko V, Behar S, Matetzky S. Relation of clinically defined spontaneous reperfusion to outcome in ST-elevation myocardial infarction. Am J Cardiol 2009; 103: 149-53.
17. Bainey KR, Fu Y, Granger CB, et al. The benefit of angiographic spontaneous reperfusion in STEMI: does it extend to diabetics? Heart 2009; 16: 1331-6.
18. Brieger D, Eagle KA, Goodman SG, et al. Acute coronary syndromes without chest pain, an underdiagnosed and undertreated high-risk group: insights from the Global Registry of Acute Coronary Events. Chest 2004; 126: 461-9.
19. Bueno H, Betriu A, Heras M, et al. Primary angioplasty vs. fibrinolysis in very old patients with acute myocardial infarction: TRIANA (TRatamiento del Infarto Agudo de miocardio eN Ancianos) randomized trial and pooled analysis with previous studies. Eur Heart J 2011; 32: 51-60.
20. Eagle KA, Goodman SG, Avezum A, Budaj A, Sullivan CM, Lopez-Sendon J. Practice variation and missed opportunities for reperfusion in ST-segment-elevation myocardial infarction: findings from the Global Registry of Acute Coronary Events (GRACE). Lancet 2002; 359: 373-7.
21. Cohen M, Gensini GF, Maritz F, et al. The role of gender and other factors as predictors of not receiving reperfusion therapy and of outcome in ST-segment elevation myocardial infarction. J Thromb Thrombolysis 2005; 19: 155-61.
22. Zhang Y, Huo Y. Early reperfusion strategy for acute myocardial infarction: a need for clinical implementation. J Zhejiang Univ Sci B 2011; 12: 629-32.
23. Armstrong PW, Collenn D, Antman E. Fibrinolysis for acute myocardial infarction. The future is here and now. Circulation 2003; 107: 2533-7.
24. O'Connor GT, Quinton HB, Traven ND, et al. Geographic variation in the treatment of acute myocardial infarction: the Cooperative Cardiovascular Project. JAMA 1999; 281(7): 627-33.
25. Randomised trial of intravenous streptokinase, oral aspirin, both, or neither among 17,187 cases of suspected acute myocardial infarction: ISIS-2 (Second International Study of Infarct Survival) Collaborative Group. Lancet 1988; 2(8607): 349-60.
26. Krumholz HM, Radford MJ, Wang Y, Chen J, Heiat A, Marciniak TA. National use and effectiveness of beta-blockers for the treatment of elderly patients after acute myocardial infarction: National Cooperative Cardiovascular Project. JAMA 1998; 280: 623-9.